Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1980 1
1981 9
1982 2
1983 2
1984 2
1985 3
1986 4
1987 8
1988 21
1989 24
1990 22
1991 28
1992 31
1993 29
1994 23
1995 22
1996 25
1997 36
1998 30
1999 19
2000 10
2001 13
2002 16
2003 18
2004 10
2005 8
2006 9
2007 10
2008 15
2009 15
2010 10
2011 12
2012 16
2013 11
2014 16
2015 12
2016 14
2017 9
2018 11
2019 14
2020 7
2021 11
Text availability
Article attribute
Article type
Publication date

Search Results

588 results
Results by year
Filters applied: . Clear all
Page 1
Anti-allergic drug azelastine suppresses colon tumorigenesis by directly targeting ARF1 to inhibit IQGAP1-ERK-Drp1-mediated mitochondrial fission.
Hu HF, Xu WW, Li YJ, He Y, Zhang WX, Liao L, Zhang QH, Han L, Yin XF, Zhao XX, Pan YL, Li B, He QY. Hu HF, et al. Theranostics. 2021 Jan 1;11(4):1828-1844. doi: 10.7150/thno.48698. eCollection 2021. Theranostics. 2021. PMID: 33408784 Free PMC article.
The target protein of azelastine was analyzed and confirmed by DARTS, WST-1, Biacore and tumor xenograft assays. ...ARF1 was identified as a direct target of azelastine. High ARF1 expression was associated with advanced stages and poor survival of CRC. ...
The target protein of azelastine was analyzed and confirmed by DARTS, WST-1, Biacore and tumor xenograft assays. ...ARF1 was identifi …
OTC drugs for seasonal allergies.
[No authors listed] [No authors listed] Med Lett Drugs Ther. 2019 Apr 22;61(1570):57-60. Med Lett Drugs Ther. 2019. PMID: 31169808 No abstract available.
Second-generation antihistamines: a comparative review.
Slater JW, Zechnich AD, Haxby DG. Slater JW, et al. Drugs. 1999 Jan;57(1):31-47. doi: 10.2165/00003495-199957010-00004. Drugs. 1999. PMID: 9951950
This article evaluates second-generation antihistamines, including acrivastine, astemizole, azelastine, cetirizine, ebastine, fexofenadine, ketotifen, loratadine, mizolastine and terfenadine, for significant features that affect choice. ...
This article evaluates second-generation antihistamines, including acrivastine, astemizole, azelastine, cetirizine, ebastine, fexofen …
Azelastine nasal spray: a review of pharmacology and clinical efficacy in allergic and nonallergic rhinitis.
Lieberman PL, Settipane RA. Lieberman PL, et al. Allergy Asthma Proc. 2003 Mar-Apr;24(2):95-105. Allergy Asthma Proc. 2003. PMID: 12776442 Review.
Azelastine hydrochloride is a pharmacologically distinct H1-receptor antagonist with a broad spectrum of antiallergic and anti-inflammatory activity. ...This article reviews the pharmacologic profile and clinical efficacy and safety of azelastine nasal spray....
Azelastine hydrochloride is a pharmacologically distinct H1-receptor antagonist with a broad spectrum of antiallergic and anti-inflam …
Azelastine hydrochloride: a review of pharmacology, pharmacokinetics, clinical efficacy and tolerability.
Bernstein JA. Bernstein JA. Curr Med Res Opin. 2007 Oct;23(10):2441-52. doi: 10.1185/030079907X226302. Curr Med Res Opin. 2007. PMID: 17723160 Review.
Azelastine has demonstrated a wide range of pharmacologic effects on chemical mediators of inflammation including leukotrienes, kinins, and platelet activating factor in vitro and in vivo. ...Clinical studies demonstrated that azelastine nasal spray can improve symp …
Azelastine has demonstrated a wide range of pharmacologic effects on chemical mediators of inflammation including leukotrienes, kinin …
Azelastine enhances the clinical efficacy of glucocorticoid by modulating MKP-1 expression in allergic rhinitis.
Luo X, Ma R, Wu X, Xian D, Li J, Mou Z, Li H. Luo X, et al. Eur Arch Otorhinolaryngol. 2015 May;272(5):1165-73. doi: 10.1007/s00405-014-3191-3. Epub 2014 Jul 25. Eur Arch Otorhinolaryngol. 2015. PMID: 25060977
Azelastine was suggested as a supplementary choice of glucocorticoid for the control of moderate to severe allergic rhinitis (AR). ...Azelastine and budesonide additively increased MKP-1 expression and inhibited ICAM-1 expression in vitro. ...
Azelastine was suggested as a supplementary choice of glucocorticoid for the control of moderate to severe allergic rhinitis (AR). .. …
Azelastine nasal spray inhibiting sympathetic function on human nasal mucosa in patients with allergy rhinitis.
Cheng LH, Lee JC, Wu PC, Lin YY, Chu YH, Wang HW. Cheng LH, et al. Rhinology. 2019 Aug 1;57(4):268-272. doi: 10.4193/Rhin18.274. Rhinology. 2019. PMID: 30887967
BACKGROUND: Azelastine hydrochloride (azelastine) nasal spray is a histamine receptor-1 (H1) antagonist often used in treating allergic rhinitis to relieve its symptoms. ...Azelastine could inhibit electrical field stimulation-induced spike mucosal contractio …
BACKGROUND: Azelastine hydrochloride (azelastine) nasal spray is a histamine receptor-1 (H1) antagonist often used in treating …
Maraviroc, celastrol and azelastine alter Chlamydia trachomatis development in HeLa cells.
Kuratli J, Leonard CA, Nufer L, Marti H, Schoborg R, Borel N. Kuratli J, et al. J Med Microbiol. 2020 Dec;69(12):1351-1366. doi: 10.1099/jmm.0.001267. Epub 2020 Nov 11. J Med Microbiol. 2020. PMID: 33180014
The CCR5 receptor antagonist maraviroc (Mara; clinically used as HIV treatment), the triterpenoid celastrol (Cel; used in traditional Chinese medicine) and the histamine H1 receptor antagonist azelastine (Az; clinically used to treat allergic rhinitis and conjunctivitis) w …
The CCR5 receptor antagonist maraviroc (Mara; clinically used as HIV treatment), the triterpenoid celastrol (Cel; used in traditional Chines …
588 results